Substance P activates osteoclast formation and osteoclastic bone resorption through the neurokinin-1 receptor

被引:10
|
作者
Goto, T [1 ]
Yamaza, T [1 ]
Kido, MA [1 ]
Tanaka, T [1 ]
机构
[1] Kyushu Univ, Grad Sch Dent Sci, Lab Oral Anat & Cell Biol, Higashi Ku, Fukuoka 8128582, Japan
关键词
osteoclasts; osteoclast-formation; bone resorption; substance P; neurokinin-1; receptor;
D O I
10.1267/ahc.34.31
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Axons containing substance P (SP) serve bone tissue, however, the role of SP in bone metabolism, particularly on osteoclastic bone resorption, is unknown. Therefore, we examined the distribution of neurokinin l-receptors (NK1-R), which have a high affinity to SP, in rat osteoclasts in vivo, and investigated the effects of SP on osteoclast formation and osteoclastic bone resorption in vitro. Using electron microscopy, immunoreactive products of NK1-R were seen in the plasma membrane and cytoplasm of osteoclasts, and were also observed in preosteoclast-like cells. Cell suspensions containing osteoclasts were prepared from neonatal rats and cultured on ivory slices. The addition of 10(-10)-10(-6)M SP caused the number of mono- and multi-nucleated tartrate-resistant acid phosphatase positive (TRAP(+)) cells to increase. The increase in TRAP(+) cells with the addition of 10(-8) M SP was inhibited by treatment with the SP receptor antagonist. In cultures on glass coverslips, time-lapse studies show that SP induced cell spreading within 5 min and maintained the spreading. The number of resorption pits excavated by the osteoclasts and the resorption area per osteoclast increased in a 48-hour incubation with 10(-8) M SP. These results suggest that SP stimulates osteoclast formation and activates osteoclastic bone resorption through NK1-R.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [1] Substance P regulates PTH secretion through the neurokinin-1 receptor
    Galvin, RJS
    Babbey, LE
    Hipskind, PA
    Lamar, T
    George, CA
    Baez, M
    Gitter, BD
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (01) : 230 - 234
  • [2] Substance P and the Neurokinin-1 Receptor: The New CRF
    Schank, Jesse R.
    Heilig, Markus
    ROLE OF NEUROPEPTIDES IN ADDICTION AND DISORDERS OF EXCESSIVE CONSUMPTION, 2017, 136 : 151 - 175
  • [3] Substance P and neurokinin-1 receptor modulation of HIV
    Ho, WZ
    Douglas, SD
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 157 (1-2) : 48 - 55
  • [4] Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors
    Goto, T.
    Nakao, K.
    Gunjigake, K. K.
    Kido, M. A.
    Kobayashi, S.
    Tanaka, T.
    NEUROPEPTIDES, 2007, 41 (01) : 25 - 31
  • [5] The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists
    Munoz, Miguel
    Gonzalez-Ortega, Ana
    Rosso, Marisa
    Jose Robles-Frias, Maria
    Carranza, Andres
    Vicente Salinas-Martin, Manuel
    Covenas, Rafael
    PEPTIDES, 2012, 38 (02) : 318 - 325
  • [6] Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer
    Covenas, Rafael
    Munoz, Miguel
    CANCERS, 2022, 14 (14)
  • [7] Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor
    Monaco-Shawver, Linda
    Schwartz, Lynnae
    Tuluc, Florin
    Guo, Chang-Jiang
    Lai, Jian Ping
    Gunnam, Satya M.
    Kilpatrick, Laurie E.
    Banerjee, Pinaki P.
    Douglas, Steven D.
    Orange, Jordan S.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 89 (01) : 113 - 125
  • [8] Substance P and its receptor neurokinin-1 in psoriasis: A pathoetiological role?
    Nordlind, Klas
    Lonne-Rahm, Sol-Britt
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1803 - 1803
  • [9] Substance P and the neurokinin-1 receptor in relation to eosinophilia in ulcerative colitis
    Jönsson, M
    Norrgård, Ö
    Forsgren, S
    PEPTIDES, 2005, 26 (05) : 799 - 814
  • [10] Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor
    Seelig, A
    Alt, T
    Lotz, S
    Holzemann, G
    BIOCHEMISTRY, 1996, 35 (14) : 4365 - 4374